Web Results



Feb 25, 2008 ... WALGREEN COMPANY et al., Plaintiffs, v. ASTRAZENECA PHARMACEUTICALS L.P. et al., Defendants. RITE AID CORPORATION et al., ...

Antitrust Scrutiny of Pharmaceutical “Product Hopping” - Gibson Dunn


Walgreen. Walgreen Co. v. AstraZeneca Pharmaceuti cals,43 decided two years after Teva, was also a ruling on a motion to dismiss. The case involved ...

Branded Drug Reformulation - Gibbons PC

www.gibbonslaw.com/Files/Publication/3427d7bf-7d12-4e65-8cb6-eb86c08337b5/Presentation/PublicationAttachment/046c8556-5185-4109-9c8e-f1fb3b924348/Federal and Drug Journal - Amoresano.pdf

Abbott Laboratories v. Teva Pharmaceuticals USA, Inc., 432 F. Supp.2d 408 (D. Del. (2006));. Walgreen Co., et al. v. AstraZeneca Pharmaceuticals L.P, et al., Civ  ...

AstraZeneca's Symbicort Inhaler Triggers Patent Suit - Law360


Jan 3, 2012 ... Texas-based Accuhale LLC hit AstraZeneca PLC with a patent ... suit Thursday, claiming the pharmaceutical giant violated federal law with ... retail pharmacies including CVS Caremark Corp. and Walgreen Co. to ... The case is Accuhale LLC v. AstraZeneca LP et al., case number 6:11-cv-00707, in the U.S. ...

CPI Antitrust Chronicle - Skadden


May 19, 2010 ... A few years later, in Walgreen Co. v. AstraZeneca Pharmaceuticals, L.P. and AstraZeneca. AB v. .... of New York v. Actavis plc et al., Case No.

Dr. Gordon Rausser Principal Consulting Areas


Sandoz (2008); Novartis Corporation v. Lupin,. Ltd. (2008); Syngenta v. Monsanto (2008, 2006); Walgreen Co. et al. v. AstraZeneca. Pharmaceuticals L.P., et al.

Product Hopping and Monopolization Standards - Schiff Hardin LLP


Jun 8, 2015 ... In Abbott Labs, et. al. v. Teva Pharmaceuticals, et. al. ... In Walgreen Co. v. AstraZeneca Pharmaceuticals, LP (534 F.Supp. 2d 146, 2008 ...

Mylan v. Warner Chilcott: A Study in Pharmaceutical Product Hopping


May 21, 2015 ... See Lisa Barons Pensabene et al., Hatch-Waxman: An Overview, PRAC. L. COMPANY ... Pharms., Inc. v. Warner Chilcott Pub. Co. (E.D. Pa. Jun. 12, 2013) ( No. 12-3824) [ ..... L.P., 534 F. Supp. 2d 146 (D.D.C. 2008) .... In granting. AstraZeneca's motion to dismiss, the Walgreen court relied on the reasoning.

Text of the Amicus Brief - Federal Trade Commission


Feb 12, 2016 ... ROCHESTER DRUG CO-OPERATIVE, INC., on behalf of itself and others ... WORKERS LOCAL 595 HEALTH AND WELFARE FUND; WALGREEN CO.; .... v. ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP; ..... Miles W. Kirkpatrick et al., Report of the American Bar Association Section of.

Mylan Pharmaceuticals, Inc. v. Warner Chilcott plc, et al. (166.21 KB)


Sep 30, 2015 ... Walgreen Co. v. Astrazeneca Pharms., L.P.,. 534 F. Supp. 2d 146 .... G. Michael Allen et al., Physician Awareness of Drug Cost: A Systematic ...

More Info

Law360's Product-Hopping Cheat Sheet For 2015 - Law360


Mar 13, 2015 ... Case: Walgreen Co. et al. v. AstraZeneca Pharmaceuticals LP et al. ... AstraZeneca, however, never pulled Prilosec from the shelves.

Drug Antitrust Issues With Daraprim And Beyond - Law360


Oct 9, 2015 ... [11] In contrast, the court in King Drug Co. of Florence v. ... AstraZeneca Pharmaceuticals LP granted a motion to dismiss even though plaintiffs .... [27] Darren S. Tucker et al., REMS: The Next Pharmaceutical Enforcement ... Ranbaxy; Turing Pharmaceuticals AG; Verizon Communications; Walgreen Co.